CDC adds funds to Sicav

CDC IXIS has added seven funds to its Luxembourg Sicav, CDC International. The funds are all US equity portfolios, managed by three US-based specialists, and are divided into three styles: growth, value and core. Two additional growth funds will be run by Loomis Sayles & Co. The first, CDC Loomis US Large Cap Growth, will be run against the Russell 1000 Growth index. The second, CDC Loomis US Small Cap Growth, will focus on medium and small-cap companies, between $500m to $1.5bn, generally equivalent to stocks listed in the Russell 2500 Growth index. Chicago-based Harris Associa...